About this article Cite this article Villaschi, A., Ferrante, G., Cannata, F
Mechanism: Stimulates pulsatile GH release Increases IGF-1 without desensitizing pituitary Specifically reduces deep abdominal fat Benefits: Reduces visceral fat while maintaining or increasing lean mass Enhances insulin sensitivity and lipid metabolism Supports training capacity in overweight or aging populations Typical Dose: 2 mg subcutaneously once daily Best taken at night before bed IGF-1 LR3: Direct Muscle Growth Stimulation IGF-1 LR3 (Long Arg3) is a modified version of IGF-1 with an extended half-life, allowing for more consistent anabolic signaling
Highlights of Prescribing Information
Am J Cardiol 86 : 10051009
This includes health needs, the environment, and lifestyle
GLP-1 receptor activity GLP-1 signalling is associated with appetite reduction, delayed gastric emptying and glucose-dependent insulin support